Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated TCM and Conventional Medicine for Severe COVID-19
NCT06714032Phase 3Completed
- Sponsor
- Henan University of Chinese Medicine
- Start
- Jan 2023
- Primary completion
- Nov 2023
- Modality
- HMF (Herbal Medicine Formulation)
- Countries
- 1
01
Overview
A Phase 3 trial of bazhengsan in coronavirus disease 2019 (COVID-19), sponsored by Henan University of Chinese Medicine. Started Jan 2023; status: completed.
02
Drugs
bazhengsan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06714032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06714032.